Retinol capsules that leave ‘skin looking younger' hailed for results ‘in a day'
Banishing pesky signs of ageing like fine lines may seem like a difficult task, one that may require expensive products or procedures, but skincare shoppers may have found an inexpensive serum that works wonders on wrinkles and restores radiance to dull, ageing skin in just a short period of time.
These RoC Retinol Capsules are available at iHerb for £30.43. They come with 30 capsules designed to be used nightly. From a leading French skincare brand, RoC, these capsules are clinically proven to deliver visible and lasting results.
Also available from Sephora, Lookfantastic and Amazon, these retinol capsules house the RoC Retinol Correxion Line Smoothing Night Serum, which is specially formulated to smooth and renew the appearance of collagen-depleted skin.
Sealed tight in single-use capsules for optimal potency, this serum combines a high concentration of pure RoC Retinol with a bio-derived antioxidant. On application, it promises a silky, lightweight fluid that drenches skin in hydration while helping to plump the appearance of fine lines and wrinkles.
The exclusive formula accelerates the removal of old, dull skin cells, supporting more even-toned and radiant-looking skin. It is perfect for use as the first step in your evening skincare routine. While 97% of users declared smoother skin in one night, others declared that elasticity appeared restored after just one night. Within a week, the complexion is set to appear more hydrated and firmer.
These capsules boast over 1100 reviews, with an impressive 75% bestowing a 5-star rating. One happy shopper shares: "I use this almost every night and absolutely love how it leaves my skin feeling. The capsules are convenient, and the serum itself is top quality. Over time, I've seen a noticeable improvement in my skin's texture and smoothness. Compared to others my age, my skin looks more youthful and radiant, which makes me believe this product truly delivers. It's definitely become a staple in my nighttime routine."
Further adoration comes from this customer who gushes: "I use this almost every night, and I love how it makes my skin feel. The capsules are easy to use, and the quality of the serum is excellent. Over time, I've noticed a real difference in my skin's texture and smoothness. Compared to my peers, my skin looks more youthful and radiant, which makes me think this product is really working. Definitely a great addition to my nighttime routine!"
A third raves: "I am not sure how it works, but it appears to be effective. My husband and I both noticed an improvement within a day. It is interesting that I could not find any information about the amount of retinol in this product. This may be due to the very small amount present. I will definitely buy it again! It's very convenient to use and looks aesthetic in my medicine cabinet. It doesn't have a strong scent. p.s. My age is 30+."
And a fourth buyer beams: " This is my go-to brand when it comes to anti-ageing skin. I've spent on some other renowned brands, but for Roc, I could confidently recommend it to my family and friends because it works. If you're looking for an anti-ageing product which doesn't break your bank, I will recommend you. It helps reduce a lot of my fine lines around my eyes and lip areas. Try it yourself. Try and guess my age. Hint: I am in my mid-40s. very much enjoy."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Spectator
2 days ago
- Spectator
Mounjaro won't be the last drug company to bow to Trump
If you need to lose a few pounds after enjoying the French or Italian food a little too much on your summer holiday, there might soon be a problem. The cost of one of the new weight loss drugs that has become so popular in recent months is about to get a lot more expensive. The American drugs giant Eli Lilly doubling the price of Mounjaro in the UK. The price of one diet pill does not make a great deal of difference. The trouble is, the decision was prompted by President Trump's determination to make the cost of medicines a lot fairer between the United States and the rest of the world. This is going to end up costing Britain, along with many other countries, a lot of money. Eli Lilly will be increasing the British price of Mounjaro, the most popular and effective weight loss injection, from £92 for a medium-sized dose to £180, and from £122 to £330 for a stronger version. The reason is simple. President Trump, with his typically blunt language, complained about how a friend of his brought 'the fat drug' in London at a far lower price than in the US despite being 'the same box made in the same plant by the same company'. More broadly, President Trump has made a big issue of the huge differences in drug prices between the US and other countries. He has imposed tariffs that could go as high as 250 per cent to force the major pharmaceutical companies to bring their manufacturing onshore and lower prices for American patients. Eli Lilly's response, quite rationally, has been to increase the price in the UK to start to close the gap and keep the President happy. Eli Lilly won't be the last pharmaceutical company to do this. Truth be told, President Trump has a point about the unfairness of drug prices in his country. On average, medicines cost 2.7 times more in the US than they do in the rest of the world. That might make sense for poor countries, but it is hard to see why developed economies in Europe, the Gulf or Asia should pay so much less for medicines than America does. In effect, the US subsidises the rest of the world, paying for the huge cost of research while the rest of the world gets drugs at far less than they would otherwise cost. But if that is rebalanced, medicines will inevitably get a lot more expensive, both for private patients and in time for the NHS as well. Given that the UK spends £34 billion a year on pharmaceuticals and that £19 billion of that comes from the NHS, that is going to be a very big bill – and one that we can barely afford.
The Guardian
5 days ago
- The Guardian
Monica Seles adapting to ‘new normal' after being diagnosed with neuromuscular disease
Monica Seles says she was diagnosed with myasthenia gravis – a neuromuscular autoimmune disease – three years ago. The nine-time grand slam singles champion says she first noticed symptoms of the disease while she was swinging her racket. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' Seles, who won her first major, the 1990 French Open, at the age of 16 and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time before this month's US Open to raise awareness of the condition. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but … can occur at any age, including childhood'. There is currently no known cure. The 51-year-old said she'd never heard of the condition until she was referred to a neurologist after noticing symptoms such as double vision and weakness in her arms – 'just blowing my hair out … became very difficult,' she said – and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles. 'So this is where – I can't emphasize enough – I wish I had somebody like me speak up about it.' The disease can also cause difficulty in swallowing, speaking and affect facial expressions. It's been three decades since Seles returned to competition at the 1995 US Open, making it to the final, more than two years after she was stabbed at a tournament in Germany. 'The way they welcomed me … after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' Seles says she is learning to live a 'new normal' and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset – hard reset – a few times. I call my first hard reset when I came to the US as a young 13-year-old [from Yugoslavia]. Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes [everything], and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing – I had to do a huge reset,' Seles said. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust. And that's what I'm doing now.' Seles won nine grand slam singles titles during her playing career, with Wimbledon being the only major she missed out on, although she did reach the final in 1992. Her 178 weeks at No 1 is sixth all-time in WTA history.
The Guardian
5 days ago
- The Guardian
Monica Seles adapting to ‘new normal' after being diagnosed with neuromuscular disease
Monica Seles says she was diagnosed with myasthenia gravis – a neuromuscular autoimmune disease – three years ago. The nine-time grand slam singles champion says she first noticed symptoms of the disease while she was swinging her racket. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' Seles, who won her first major, the 1990 French Open, at the age of 16 and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time before this month's US Open to raise awareness of the condition. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but … can occur at any age, including childhood'. There is currently no known cure. The 51-year-old said she'd never heard of the condition until she was referred to a neurologist after noticing symptoms such as double vision and weakness in her arms – 'just blowing my hair out … became very difficult,' she said – and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles. 'So this is where – I can't emphasize enough – I wish I had somebody like me speak up about it.' The disease can also cause difficulty in swallowing, speaking and affect facial expressions. It's been three decades since Seles returned to competition at the 1995 US Open, making it to the final, more than two years after she was stabbed at a tournament in Germany. 'The way they welcomed me … after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' Seles says she is learning to live a 'new normal' and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset – hard reset – a few times. I call my first hard reset when I came to the US as a young 13-year-old [from Yugoslavia]. Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes [everything], and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing – I had to do a huge reset,' Seles said. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust. And that's what I'm doing now.' Seles won nine grand slam singles titles during her playing career, with Wimbledon being the only major she missed out on, although she did reach the final in 1992. Her 178 weeks at No 1 is sixth all-time in WTA history.
